2016
DOI: 10.1016/j.etap.2016.07.014
|View full text |Cite
|
Sign up to set email alerts
|

Zidovudine and isoniazid induced liver toxicity and oxidative stress: Evaluation of mitigating properties of silibinin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
22
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(25 citation statements)
references
References 34 publications
1
22
0
Order By: Relevance
“…For the TB treatment, generally isoniazid is included in the first-line anti-tuberculosis medication (it has been used for more than 50 years). This drug is associated with hepatotoxicity risk and diseases such as hepatitis and peripheral neuropathy [43,44]. Additionally, it has been demonstrated that if isoniazid is given alone it will rapidly lead to drug resistance.…”
Section: Discussionmentioning
confidence: 99%
“…For the TB treatment, generally isoniazid is included in the first-line anti-tuberculosis medication (it has been used for more than 50 years). This drug is associated with hepatotoxicity risk and diseases such as hepatitis and peripheral neuropathy [43,44]. Additionally, it has been demonstrated that if isoniazid is given alone it will rapidly lead to drug resistance.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, in a study of anti-retroviral drugs-induced oxidative stress and liver toxicity in rats, silibinin (100 mg/kg p.o. ), one of the most well-known and potent hepatoprotective flavonolignanes isolated from Silybum marianum , improved all biochemical and pathological parameters, confirming its hepatoprotective and antioxidant potential [ 259 ]. These studies suggest that dietary intake of flavonoids contributes to the prevention or treatment of hepatotoxicity induced by the exposure to xenobiotics and other environmental factors.…”
Section: Dietary Natural Pigments With Biological Activitymentioning
confidence: 97%
“…The d4T treatment can cause mild to transient Raghu and Karthikeyan, 2016;Raghu et al, 2015;Banerjee et al, 2013;Brinkman et al, 1998;Dubin and Braffman, 1989 Stavudine Elevation of liver toxicity marker enzymes, lactic acidosis, inhibition of mitochondrial oxidation of FFA -macrovesicular steatosis van Griensven et al, 2010;Gerschenson et al, 2001;Johri et al, 2000;Lea and Faulds, 1996 Lamivudine Elevation in serum ALT levels in patients co-infected with chronic HBV, elevation of hepatotoxic and lipid marker enzymes in serum and plasma Jesudas et al, 2016;Johri et al, 2000 Non-nucleoside reverse transcriptase inhibitors (NNRTIs) Nevirapine Jaundice, hepatitis, hepatic necrosis, hepatic failure, elevation of liver marker enzymes (AST/ALT) in chronic therapy Ajulo et al, 2015;Bera et al, 2012;Hitti et al, 2004 Efavirenz Retention of bile constituents in hepatocytes -cholestasis -hepatocytes apoptosis, inhibits bile acid transport in human/rat hepatocytes, high levels of elevation of AST/ALT, hepatic steatotic changes, mitochondria and ER stress Thamrongwonglert et al, 2016;Patil et al, 2015;Apostolova et al, 2013;McRae et al, 2006 Protease inhibitors (PIs) Ritonavir Induction of hepatocytes apoptosis through caspase-3 cascade system Inhibits bile acid transport in human/rat hepatocytes Increased risk of hepatotoxicity in HIV+TB infected patients with rifampicin treatment Mchunu et al, 2016;Kuang et al, 2014;Schmitt et al, 2009 Nelfinavir elevation in liver marker enzymes due to hepatotoxicity which occurs in up to 50% of patients and lactic acidosis is often reported in these patients with high mortality rate (van Griensven et al, 2010;Lea and Faulds, 1996). In primates, chronic exposure of d4T has been reported to induce mitochondrial toxicity and there was a significant destruction of hepatocytes mitochondrial DNA found in the liver of d4T-exposed monkeys (Gerschenson, et al, 2001).…”
Section: Stavudine (D4t)mentioning
confidence: 99%
“…HIV-infected individuals are often co-infected by many bacterial infections, including Tuberculus bacilli. These patients are treated with anti-tubercular drugs daily, for several months, depending upon the severity of infection, in addition to their routinely administered regimens of anti-retroviral drugs (Mchunu et al, 2016;Raghu and Karthikeyan, 2016). HIV-infected individuals are often co-infected by many bacterial infections, including Tuberculus bacilli.…”
Section: Ritonavirmentioning
confidence: 99%